Skip to main content
. Author manuscript; available in PMC: 2022 Mar 15.
Published in final edited form as: J Neuroimmunol. 2020 Dec 27;352:577468. doi: 10.1016/j.jneuroim.2020.577468

Table 1.

EAE disease scores were decreased in T3, Sob and Sob-AM2 groups

Group Number Survived EAE incidence# Mean day of onset* Total EAE scores+ Maximum clinical score on any given day
Vehicle 24 18 17 15.4 31.2 7
T3 24 22 14 15.8 19.0 7
Sobetirome 16 16 11 18.1 10.8 6
Sob AM2 24 24 10 18.7 4.3 5
*

only those mice who showed disease were included in mean day onset

#

treatment was started before onset of disease so treatment is delaying and blocking disease

+

ANOVA significant p<0.0001